Tammy Jean Williams, ARNP

Tammy Williams practices at Lake Butler Medical Clinic Inc in Lake Butler, Florida.

Tammy Williams' NPI, 1285877258, was assigned on April 7, 2009. Tammy Williams holds Florida license 2613912.

Tammy Williams' primary practice is Lake Butler Medical Clinic Inc, at 675 E Main St, Lake Butler, FL 32054 in Union County. The practice phone is (386) 496-1328.

Tammy Williams' primary practice is Lake Butler Medical Clinic Inc in Lake Butler, Florida. The medical group on file is Lake Butler Medical Clinic. Dmand AI also links Tammy Williams to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tammy Williams practices. Vendor and product names are available with a free account.

Family is Tammy Williams' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Tammy Williams is licensed in Florida.

Dmand AI lists chronic obstructive pulmonary disease (COPD), high cholesterol, tobacco use and underactive thyroid among the conditions Tammy Williams treats.

CMS data shows 46 Medicare services from Tammy Williams across 2 procedure codes in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $3,316 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Tammy Williams in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tammy Williams' median patient age at 70, with 61% women.

In 2024, Tammy Williams wrote 1,298 Medicare Part D claims for 302 patients. 90% of them were for generic drugs. CMS names the drug for 800 of them, across 32 drugs with 11 or more claims each, at $34,737 in total drug cost.

Tammy Williams accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 74 general payments to Tammy Williams from 18 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $343.